• Start to finish partner for Diagnostics
  • Clinical trial support (GLP, GCLP)
  • Technology and platform agnostic
  • Cost-effective, risk-mitigated approach and clear strategic guidance
  • Precision medicine, Biomarker driven patient stratification
  • Regulatory expertise (IDE, Q-sub, 510(k), De Novo, PMA (single site and full IVD), BIMO)
  • Orthogonal method validation, multi-site validation studies, and head to head assay comparisons
  • CLIA/CAP consulting and Bioincubator program

Come talk to us. Call (866) 225-9195 or fill out this form.

Start a Discussion

PHILIP D. COTTERPHILIP D. COTTER
PhD, FACMG, FFSC (RCPA)
Principal

MATHEW W. MOOREMATHEW W. MOORE
PhD
Principal

Meet Our Team
About Research Dx
ResearchDx is a full-service diagnostic development organization, providing a ‘start-finish’ partnership for the co-development of companion diagnostics.  At RDx, we design, manage, de-risk and coordinate every aspect of the diagnostics development process, from biomarker discovery, assay design and validation, clinical trial management and logistics, and regulatory submission. As a uniquely technology and platform agnostic solutions provider, we look at all available options to best support your project.
As your single CLIA, CAP and ISO13485 certified partner, we understand the challenges of CDx development and strive to provide a cost effective, de-risked path and clear strategic guidance. RDx provides a flexible process that is agile and adaptable and we dedicate ourselves to the success of our partners.